| Video
Practitioners are feeling the pinch of prescribing opioids, but what to do instead? Drs. McPherson and McPherson call out for some good old common sense.
| Video
Ravi Prasad, a Clinical Associate Professor at Stanford University, discusses the multifactorial dynamic of treatment and psychology as it applies to pain.
| Video
Dr. Prasad discusses opioids vs nonpharmaceuticals, health costs vs benefits, pain scores vs daily functioning--and keeping the patient's needs uppermost in importance.
| Video
The biologic response to stress is a struggle for homeostasis, and a better understanding of the process may inform better decisions in pain management. Dr. Blatman offers some insights, and the beneficial impact of nutritional intervention.
| Video
Sleep quality has long been a concern in the practice of pain management, and evidence suggests a greater significance to sleep issues and apnea than has been generally considered. Dr. Blatman discusses the relationship of sleep fragmentation to head and neck pain, and offers guidance on integrative...
| Video
Increasing concern over long-term opioid therapy for chronic noncancer pain has prompted interest in opioid sparing alternatives. Is cannabis useful as an opioid sparing approach to pain management? Dr. Badiola considers the evidence.
| Video
Dr. Badiola summarizes some of the challenges to accurate diagnosis and pinpointing of spinal pain, and considers some interventional options in the treatment armamentarium as well as where these fit in the multimodal spectrum
| Video
Myelopathies--spinal cord disorders--are associated with multiple medical conditions. Dr. Argoff provides an overview of the causes of myelopathy, and discusses differential diagnosis and options for treatment.
| Video
Multidrug therapy has been part of the chronic pain treatment armamentarium for many years. In this segment, Dr. Argoff reviews the concept and offers guidance on its engagement.
| Video
Are clinical treatment guidelines useful in actually treating patients? Dr. Argoff discusses the guideline development process, and why the individual patient sometimes gets "lost in translation".